by Eric Emerson | Apr 27, 2020 | Insights
Chief Operation Officer, Crumdale Partners’ Pharmacy Division (Transformation Rx) Jason Lohman has recently joined Crumdale Partners as the Chief Operating Officer of Crumdale Partners’ Pharmacy Division (Transformation Rx). His primary responsibilities are product...
by Eric Emerson | Mar 17, 2020 | Insights
On March 11th, the Internal Revenue Service (IRS) announced that high-deductible health plans (HDHPs) can pay first dollar coverage for 2019 Novel Coronavirus (COVID-19)-related testing and treatment, without jeopardizing their status. The IRS is taking these steps...
by Eric Emerson | Mar 12, 2020 | Insights
Those in the stop loss market have heard the phrase “leveraged trend” when discussing renewal calculations with your stop loss carrier. While few understand how this works, all have seen its’ significant impact on your clients’ stop loss renewals. What is leveraged...
by Eric Emerson | Feb 12, 2020 | Insights
It is estimated over 75,000 people worldwide have been infected with the coronavirus, with death figures approaching 2800 people. The fear of this potentially deadly virus has employers beginning to take steps to protect their employees. Coronavirus (2019-nCoV) was...
by Eric Emerson | Feb 5, 2020 | Insights
On January 31st, 2020, the U.S. Food and Drug Administration (FDA) approved Palforzia to reduce the risk of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. Peanut allergy is a condition in which the body’s immune system...
Recent Comments